[1] Kfir Y, Buchner A, Hansen LS.Reactive lesions of the gingiva. A clinicopathological study of 741 cases[J]. J Periodontol, 1980, 51(11): 655-661. [2] Cai Y, Sun R, He KF, et al.Sclerotherapy for the recurrent granulomatous epulis with pingyangmycin[J]. Med Oral Patol Oral Cir Bucal, 2017, 22(2): e214-e218. [3] Truschnegg A, Acham S, Kiefer BA, et al.Epulis: a study of 92 cases with special emphasis on histopathological diagnosis and associated clinical data[J]. Clin Oral Investig, 2016, 20(7): 1757-1764. [4] Jeyaraj P, Bandyopadhyay TK, Naresh N, et al.Value of immunohistochemistry in diagnosing a rare case of maxillofacial plasma cell granuloma masquerading as a gingival epulis[J]. J Maxillofac Oral Surg, 2015, 14(1): 40-45. [5] Nakayama Y, Matsui S, Noda K, et al.Amelotin gene expression is temporarily being upregulated at the initiation of apoptosis induced by TGFbeta1 in mouse gingival epithelial cells[J]. Apoptosis, 2016, 21(10): 1057-1070. [6] Cheng R, Hu T, Bhowmick NA.Be resistant to apoptosis: a host factor from gingival fibroblasts[J]. Cell Death Dis, 2015, 6: e2009. [7] Lu QL, Poulsom R, Wong L, et al.Bcl-2 expression in adult and embryonic non-haematopoietic tissues[J]. J Pathol, 1993, 169(4): 431-437. [8] Jung JY, Jeong YJ, Jeong TS, et al.Inhibition of apoptotic signals in overgrowth of human gingival fibroblasts by cyclosporin A treatment[J]. Arch Oral Biol, 2008, 53(11): 1042-1049. [9] Saito K, Mori S, Tanda N, et al.Immunolocalizaiton of c-Myc and bcl-2 proto-oncogene products in gingival hyperplasia induced by nifedipine and phenytoin[J]. J Periodontol, 2000, 71(1): 44-49. [10] Arunachalam LT, Rao S.Immunolocalization of Bcl-2 oncoprotein in amlodipine-induced gingival overgrowth[J]. Indian J Dent Res, 2013, 24(2): 255-260. [11] Shimizu Y, Kataoka M, Seto H, et al.Nifedipine induces gingival epithelial hyperplasia in rats through inhibition of apoptosis[J]. J Periodontol, 2002, 73(8): 861-867. [12] Nagata S.Apoptosis and clearance of apoptotic cells[J]. Annu Rev Immunol, 2018, 36: 489-517. [13] Opferman JT, Kothari A.Anti-apoptotic BCL-2 family members in development[J]. Cell Death Differ, 2018, 25(1): 37-45. [14] Ashkenazi A, Fairbrother WJ, Leverson JD, et al.From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nat Rev Drug Discov, 2017, 16(4): 273-284. [15] Strzyz P.Cell death: BCL-2 proteins feed their own expression[J]. Nat Rev Mol Cell Biol, 2017, 18(11): 652-653. [16] Czabotar PE, Lessene G, Strasser A, et al.Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy[J]. Nat Rev Mol Cell Biol, 2014, 15(1): 49-63. [17] 张明珠, 张蕾, 朱红, 等. bcl-2蛋白在血管性和纤维性牙龈瘤中的表达和意义[J]. 牙体牙髓牙周病学杂志, 2013, 23(8): 503-506. [18] Fulda S, Vucic D.Targeting IAP proteins for therapeutic intervention in cancer[J]. Nat Rev Drug Discov, 2012, 11(2): 109-124. [19] Salvesen GS, Duckett CS.IAP proteins: blocking the road to death's door[J]. Nat Rev Mol Cell Biol, 2002, 3(6): 401-410. |